About Alembic Limited
Data last updated: 06 January 2026
Alembic Limited is a public limited company based in Baroda, Gujarat, India, a subsidiary of Nirayu Limited. It specialises in api manufacturers, a part of the broader pharmaceuticals sector. Incorporated on 30 July 1907, the company has been in operation for over 119 years.
Registered with ROC Ahmedabad under CIN L26100GJ1907PLC000033. Listed on BSE: 506235 and NSE: ALEMBICLTD.
Capital: an authorised share capital of ₹60 Cr and a paid-up capital of ₹51.36 Cr. Formerly known as Alembic Chemical Works Co Ltd. It is led by directors including Kevalkumar B Thakkar and Girish Srinivasiah Hirode.
Last AGM: 12 August 2025. Financial statements filed for year ended 31 March 2025. Office: Alembic Road, Baroda, Gujarat, India – 390003.
As per the financials filed for FY 2025, the company reported a revenue of ₹296.78 Cr, a growth of 40% compared to the previous year.
The company has a workforce of approximately 287 employees as per the latest available data. It operates as a subsidiary of Nirayu Limited. Its group structure includes 1 subsidiary.
The company is associated with 1 brand - Alembic Limited. As per MCA filings, the company has open charges of ₹67 Cr and satisfied charges of ₹446.2 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website alembiclimited.com.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media**************
-
Registered AddressAlembic Road, Baroda, Gujarat, India – 390003
-
IndustryPharma, API Manufacturers
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Alembic Limited
Alembic Limited has one previous CIN (Corporate Identification Number): U26100GJ1907PLC000033. The current CIN is L26100GJ1907PLC000033, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L26100GJ1907PLC000033 | Current |
| U26100GJ1907PLC000033 | Previous |
Associated Brands with Alembic Limited
Alembic Limited operates one associated brand: Alembic Limited. These brands represent Alembic Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Active pharmaceutical ingredients are manufactured by Alembic. | alembiclimited.com |
Competitors & Alternatives of Alembic Limited
Brands and companies operating in the same space as Alembic Limited include Merck, Roivant Sciences, AbbVie and 7 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Merck
|
Pharmaceutical products are manufactured and marketed worldwide. | Kenilworth, United Kingdom, United Kingdom | 1891 |
Roivant Sciences
|
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | New York, United States, United States | 2014 |
AbbVie
|
Biopharmaceutical research and drug development are conducted globally by AbbVie. | Chicago, United States, United States | 2012 |
Lilly
|
Traditional pharmaceutical medicines are developed for multiple health fields. | United States | 1876 |
Gilead
|
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | Foster City, United States, United States | 1987 |
United Therapeutics
|
Treatments for chronic and life-threatening diseases are developed and commercialized. | Silver Spring, United States, United States | 1998 |
Roche
|
Pharmaceuticals and diagnostics kits are developed for various diseases. | Basel, Switzerland, Switzerland | 1896 |
Ascendis Pharma
|
Long-acting prodrug therapies are developed for endocrine and rare diseases. | Hellerup, Denmark, Denmark | 2007 |
MorphoSys
|
Therapeutic antibodies for cancer and other diseases are developed. | Planegg, Germany, Germany | 1992 |
Vertex Pharmaceuticals
|
Developer of drugs for the treatment of multiple disorders | United States | 1989 |
Business Activity of Alembic Limited
Alembic Limited is engaged in principal business activities including manufacturing and real estate, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products, real estate activities with own or leased property. The company has 2 registered principal business activity segments, demonstrating its operational diversity and market reach.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | ********* |
| L | Real Estate | L1 | Real estate activities with own or leased property | ********* |
Auditor Details of Alembic Limited
Alembic Limited is audited by CNK & ASSOCIATES LLP (ICAI peer reviewed, certificate valid till 2026-07-31) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.
| Name | Financial year | Audit opinion |
|---|---|---|
| CNK & ASSOCIATES LLP (ICAI peer reviewed, certificate valid till 2026-07-31) | FY 2026 | Declaration of unmodified opinion |
Board of Directors of Alembic Limited
Alembic Limited is currently managed by 11 directors, with 25 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kevalkumar B Thakkar | Company Secretary | 01 Sep 2023 | 2 Years 10 Months | Current |
|
Girish Srinivasiah Hirode
Also directs:
Alembic Limited
|
Director | 10 Aug 2023 | 2 Years 10 Months | Current |
| Rasesh Jayant Shah | Deputy Nodal Officer | 01 Jun 2023 | 3 Years 1 Months | Current |
| Udit Chirayu Amin | Managing Director | 28 Mar 2016 | 10 Years 3 Months | Current |
|
Mayurdhvaj Dilipsinh Jadeja
Also directs:
Alembic Limited, Ratna Nico Chem Pvt Ltd
|
Director | 07 Feb 2025 | 1 Years 5 Months | Current |
| Rati Ajay Desai | Director | 13 Aug 2019 | 6 Years 10 Months | Current |
Financials of Alembic Limited FY 2026 filings available
Alembic Limited reported revenue of ₹239.99 Cr (up 8.16% YoY) for FY 2026. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹239.99 Cr | ₹221.89 Cr | ₹157.49 Cr | ₹127.24 Cr | ₹78.22 Cr | ₹73.52 Cr | ₹73.93 Cr |
| Other Income | ₹72.97 Cr | ₹74.89 Cr | ₹54.77 Cr | ₹64.26 Cr | ₹89.18 Cr | ₹10.27 Cr | ₹93.4 Cr |
| Total Income | ₹312.96 Cr | ₹296.78 Cr | ₹212.26 Cr | ₹191.51 Cr | ₹167.4 Cr | ₹83.79 Cr | ₹167.33 Cr |
| Cost of Materials Consumed | ₹13.88 Cr | ₹8 Cr | ₹8.62 Cr | ₹6.92 Cr | ₹8.53 Cr | ₹11.77 Cr | ₹24.59 Cr |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | ₹2.55 Cr | ₹1.11 Cr | ₹52.52 Lakh | -₹60.18 Lakh | ₹2.46 Cr | -₹2.39 Cr | ₹6.84 Cr |
| Employee Benefit Expense | ₹37.44 Cr | ₹27.31 Cr | ₹23.03 Cr | ₹24.04 Cr | ₹21.47 Cr | ₹22.6 Cr | ₹20.79 Cr |
| Finance Costs | ₹2.28 Cr | ₹2.47 Cr | ₹1.11 Cr | ₹46.54 Lakh | ₹38.91 Lakh | ₹36.2 Lakh | ₹28.8 Lakh |
| Depreciation & Amortisation | ₹12.39 Cr | ₹10.63 Cr | ₹7.84 Cr | ₹6.72 Cr | ₹4.86 Cr | ₹3.94 Cr | ₹3.23 Cr |
| Other Expenses | ₹95.66 Cr | ₹91.75 Cr | ₹68.45 Cr | ₹56.55 Cr | ₹31.83 Cr | ₹30.47 Cr | ₹18.43 Cr |
| Total Expenses | ₹164.2 Cr | ₹141.28 Cr | ₹109.57 Cr | ₹94.1 Cr | ₹69.54 Cr | ₹66.75 Cr | ₹74.16 Cr |
| Profit Before Exceptional Items & Tax | ₹148.76 Cr | ₹155.5 Cr | ₹102.69 Cr | ₹97.41 Cr | ₹97.86 Cr | ₹17.04 Cr | ₹93.17 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹0 | -₹10.61 Cr | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹148.76 Cr | ₹155.5 Cr | ₹102.69 Cr | ₹86.8 Cr | ₹97.86 Cr | ₹17.04 Cr | ₹93.17 Cr |
| Total Tax Expense | ₹22.83 Cr | ₹10.93 Cr | ₹9.82 Cr | ₹6.18 Cr | ₹11.66 Cr | ₹3.2 Cr | ₹13.09 Lakh |
| Net Profit | ₹317.38 Cr | ₹310.68 Cr | ₹268.62 Cr | ₹190.65 Cr | ₹222.06 Cr | ₹342.84 Cr | ₹329.12 Cr |
| attributable to Owners | ₹229.83 Cr | ₹310.68 Cr | ₹268.62 Cr | ₹190.65 Cr | ₹222.06 Cr | ₹342.84 Cr | ₹329.12 Cr |
| attributable to NCI | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Other Comprehensive Income | -₹87.55 Cr | -₹34.32 Cr | -₹59.72 Cr | -₹214.11 Cr | ₹106.85 Cr | ₹344.65 Cr | -₹17.21 Cr |
| Total Comprehensive Income | ₹229.83 Cr | ₹276.36 Cr | ₹208.9 Cr | -₹23.46 Cr | ₹328.91 Cr | ₹687.49 Cr | ₹311.9 Cr |
| EBITDA (computed) | ₹163.43 Cr | ₹168.6 Cr | ₹111.63 Cr | ₹104.6 Cr | ₹103.11 Cr | ₹21.34 Cr | ₹96.68 Cr |
| Basic EPS | ₹12.36 | ₹12.10 | ₹10.46 | ₹7.43 | ₹8.65 | ₹13.35 | ₹12.82 |
| Diluted EPS | ₹12.36 | ₹12.10 | ₹10.46 | ₹7.43 | ₹8.65 | ₹0.00 | ₹12.82 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Total Assets | ₹2,589.51 Cr | ₹2,503 Cr | ₹2,328.77 Cr | ₹2,204.58 Cr |
| Non-current Assets | ₹2,392.27 Cr | ₹2,298.14 Cr | ₹2,191.38 Cr | ₹2,032.45 Cr |
| Current Assets | ₹197.24 Cr | ₹204.87 Cr | ₹137.39 Cr | ₹172.14 Cr |
| Property, Plant & Equipment | ₹169.95 Cr | ₹135.33 Cr | ₹130.54 Cr | ₹131.83 Cr |
| Inventories | ₹52.24 Cr | ₹99.39 Cr | ₹92.6 Cr | ₹88.61 Cr |
| Trade Receivables | ₹31.9 Cr | ₹29.97 Cr | ₹19.76 Cr | ₹23.45 Cr |
| Cash & Equivalents | ₹1.41 Cr | ₹2.71 Cr | ₹1.26 Cr | ₹93.18 Lakh |
| Equity (Net Worth) | ₹2,445.09 Cr | ₹2,338.59 Cr | ₹2,185.56 Cr | ₹2,078.03 Cr |
| Equity Share Capital | ₹51.36 Cr | ₹51.36 Cr | ₹51.36 Cr | ₹51.36 Cr |
| Borrowings (Non-current) | ₹6.61 Cr | ₹10.67 Cr | ₹7.39 Cr | ₹0 |
| Borrowings (Current) | ₹4.03 Cr | ₹3.78 Cr | ₹1.76 Cr | ₹0 |
| Total Debt (computed) | ₹10.64 Cr | ₹14.45 Cr | ₹9.15 Cr | ₹0 |
| Current Liabilities | ₹101.3 Cr | ₹110.47 Cr | ₹90.32 Cr | ₹83.81 Cr |
| Total Liabilities | ₹144.42 Cr | ₹164.41 Cr | ₹143.21 Cr | ₹126.55 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | ₹120.07 Cr | ₹86.37 Cr | ₹22.69 Cr | ₹38.85 Cr | -₹17.75 Cr |
| Investing Cash Flow | -₹53.86 Cr | -₹26.58 Cr | ₹25.84 Cr | ₹7.3 Cr | ₹18.85 Cr |
| Financing Cash Flow | -₹67.5 Cr | -₹58.34 Cr | -₹48.19 Cr | -₹46.39 Cr | -₹5.82 Cr |
| Capital Expenditure | ₹38.25 Cr | ₹6.58 Cr | ₹1.39 Cr | ₹4.68 Lakh | ₹1.02 Cr |
| Free Cash Flow (computed) | ₹81.82 Cr | ₹79.79 Cr | ₹21.29 Cr | ₹38.81 Cr | -₹18.77 Cr |
| Dividends Paid | ₹61.41 Cr | ₹61.17 Cr | ₹56.23 Cr | ₹45.92 Cr | ₹5.15 Cr |
| Net Change in Cash | -₹1.3 Cr | ₹1.45 Cr | ₹32.91 Lakh | -₹23.97 Lakh | -₹4.72 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹60.04 Cr | ₹74.34 Cr | ₹55.86 Cr | ₹49.75 Cr | ₹60.27 Cr | ₹57.92 Cr | ₹52.91 Cr | ₹50.78 Cr | ₹49.04 Cr | ₹39.33 Cr | ₹32.28 Cr | ₹36.84 Cr |
| Other Income | ₹2.14 Cr | ₹2.31 Cr | ₹64.92 Cr | ₹3.59 Cr | ₹2.96 Cr | ₹4.37 Cr | ₹65.6 Cr | ₹1.96 Cr | ₹2.04 Cr | ₹2.23 Cr | ₹47.87 Cr | ₹2.63 Cr |
| Total Income | ₹62.18 Cr | ₹76.65 Cr | ₹120.78 Cr | ₹53.34 Cr | ₹63.23 Cr | ₹62.29 Cr | ₹118.52 Cr | ₹52.74 Cr | ₹51.08 Cr | ₹41.55 Cr | ₹80.15 Cr | ₹39.47 Cr |
| Cost of Materials Consumed | ₹4.04 Cr | ₹3.85 Cr | ₹2.53 Cr | ₹3.45 Cr | ₹1.92 Cr | ₹1.81 Cr | ₹1.41 Cr | ₹2.86 Cr | ₹3.23 Cr | ₹1.58 Cr | ₹2.46 Cr | ₹1.34 Cr |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | -₹64.56 Lakh | ₹1.05 Cr | ₹40.34 Lakh | ₹1.74 Cr | -₹2.62 Lakh | -₹88.26 Lakh | ₹70.81 Lakh | ₹1.31 Cr | -₹1.02 Cr | -₹34.46 Lakh | -₹58.05 Lakh | ₹2.47 Cr |
| Employee Benefit Expense | ₹11.74 Cr | ₹10.32 Cr | ₹7.55 Cr | ₹7.83 Cr | ₹6.5 Cr | ₹6.56 Cr | ₹6.52 Cr | ₹7.73 Cr | ₹5.55 Cr | ₹5.58 Cr | ₹5.63 Cr | ₹6.27 Cr |
| Finance Costs | ₹56.81 Lakh | ₹55.29 Lakh | ₹56.41 Lakh | ₹59.33 Lakh | ₹62.11 Lakh | ₹68.7 Lakh | ₹67.47 Lakh | ₹48.83 Lakh | ₹47.53 Lakh | ₹36.79 Lakh | ₹13.49 Lakh | ₹13.05 Lakh |
| Depreciation & Amortisation | ₹3.34 Cr | ₹3.44 Cr | ₹2.82 Cr | ₹2.79 Cr | ₹2.75 Cr | ₹2.69 Cr | ₹2.68 Cr | ₹2.5 Cr | ₹1.48 Cr | ₹2.66 Cr | ₹1.86 Cr | ₹1.83 Cr |
| Other Expenses | ₹24.69 Cr | ₹31.67 Cr | ₹22.14 Cr | ₹17.15 Cr | ₹24.55 Cr | ₹24.04 Cr | ₹24.68 Cr | ₹18.48 Cr | ₹17.13 Cr | ₹20.83 Cr | ₹14.61 Cr | ₹15.88 Cr |
| Total Expenses | ₹43.74 Cr | ₹50.89 Cr | ₹36 Cr | ₹33.56 Cr | ₹36.32 Cr | ₹34.9 Cr | ₹36.69 Cr | ₹33.37 Cr | ₹26.85 Cr | ₹30.67 Cr | ₹24.12 Cr | ₹27.93 Cr |
| Profit Before Exceptional Items & Tax | ₹18.44 Cr | ₹25.76 Cr | ₹84.78 Cr | ₹19.78 Cr | ₹26.92 Cr | ₹27.39 Cr | ₹81.83 Cr | ₹19.37 Cr | ₹24.23 Cr | ₹10.88 Cr | ₹56.03 Cr | ₹11.55 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹18.44 Cr | ₹25.76 Cr | ₹84.78 Cr | ₹19.78 Cr | ₹26.92 Cr | ₹27.39 Cr | ₹81.83 Cr | ₹19.37 Cr | ₹24.23 Cr | ₹10.88 Cr | ₹56.03 Cr | ₹11.55 Cr |
| Total Tax Expense | ₹8.83 Cr | ₹3.29 Cr | ₹8.72 Cr | ₹1.99 Cr | ₹3.17 Cr | ₹1.3 Cr | ₹4.51 Cr | ₹1.95 Cr | ₹2.94 Cr | ₹96.27 Lakh | ₹4.32 Cr | ₹1.59 Cr |
| Net Profit | ₹67.13 Cr | ₹60.13 Cr | ₹128.49 Cr | ₹61.64 Cr | ₹68.45 Cr | ₹65.39 Cr | ₹121.02 Cr | ₹55.82 Cr | ₹72.15 Cr | ₹61.42 Cr | ₹90.68 Cr | ₹44.38 Cr |
| attributable to Owners | -₹33.87 Cr | ₹60.13 Cr | ₹128.49 Cr | ₹61.64 Cr | ₹68.45 Cr | ₹65.39 Cr | ₹121.02 Cr | ₹55.82 Cr | ₹72.15 Cr | ₹61.42 Cr | ₹90.68 Cr | ₹44.38 Cr |
| attributable to NCI | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Other Comprehensive Income | -₹100.99 Cr | -₹116.97 Cr | ₹125.97 Cr | ₹4.45 Cr | -₹21.32 Cr | -₹20.35 Cr | -₹31.18 Cr | ₹38.54 Cr | -₹53.66 Cr | -₹14 Cr | -₹27.34 Cr | ₹35.27 Cr |
| Total Comprehensive Income | -₹33.87 Cr | -₹56.84 Cr | ₹254.46 Cr | ₹66.09 Cr | ₹47.13 Cr | ₹45.04 Cr | ₹89.84 Cr | ₹94.36 Cr | ₹18.49 Cr | ₹47.42 Cr | ₹63.34 Cr | ₹79.65 Cr |
| EBITDA (computed) | ₹22.35 Cr | ₹29.75 Cr | ₹88.16 Cr | ₹23.17 Cr | ₹30.29 Cr | ₹30.77 Cr | ₹85.19 Cr | ₹22.36 Cr | ₹26.18 Cr | ₹13.91 Cr | ₹58.03 Cr | ₹13.51 Cr |
| Basic EPS | ₹2.61 | ₹2.34 | ₹5.00 | ₹2.40 | ₹2.67 | ₹2.55 | ₹4.71 | ₹2.17 | ₹2.81 | ₹2.39 | ₹3.53 | ₹1.73 |
| Diluted EPS | ₹2.61 | ₹2.34 | ₹5.00 | ₹2.40 | ₹2.67 | ₹2.55 | ₹4.71 | ₹2.17 | ₹2.81 | ₹2.39 | ₹3.53 | ₹1.73 |
| Segment · Q4 FY26 (latest quarter) | Revenue | Result (PBIT) | Assets | Liabilities |
|---|---|---|---|---|
| Active Pharmaceutical Ingredients Business | ₹9.83 Cr | -₹1.17 Cr | ₹180.81 Cr | ₹34.8 Cr |
| Real Estate Business | ₹50.21 Cr | ₹20.97 Cr | ₹515.78 Cr | ₹81.48 Cr |
| Segment · FY 2026 (annual) | Revenue | Result (PBIT) | Assets | Liabilities |
|---|---|---|---|---|
| Active Pharmaceutical Ingredients Business | ₹46.59 Cr | ₹5.65 Cr | - | - |
| Real Estate Business | ₹193.4 Cr | ₹81.17 Cr | - | - |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹231.93 Cr | ₹214.36 Cr | ₹152.25 Cr | ₹123.16 Cr | ₹75.97 Cr | ₹72.3 Cr | ₹73.69 Cr |
| Other Income | ₹72.77 Cr | ₹74.51 Cr | ₹54.62 Cr | ₹64.11 Cr | ₹89.09 Cr | ₹9.97 Cr | ₹93.47 Cr |
| Total Income | ₹304.7 Cr | ₹288.87 Cr | ₹206.87 Cr | ₹187.27 Cr | ₹165.06 Cr | ₹82.27 Cr | ₹167.16 Cr |
| Cost of Materials Consumed | ₹13.88 Cr | ₹8 Cr | ₹8.62 Cr | ₹6.92 Cr | ₹8.53 Cr | ₹11.77 Cr | ₹24.59 Cr |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | ₹2.55 Cr | ₹1.11 Cr | ₹52.52 Lakh | -₹60.18 Lakh | ₹2.46 Cr | -₹2.39 Cr | ₹6.84 Cr |
| Employee Benefit Expense | ₹37.44 Cr | ₹27.31 Cr | ₹23.03 Cr | ₹24.04 Cr | ₹21.47 Cr | ₹22.6 Cr | ₹20.79 Cr |
| Finance Costs | ₹1.57 Cr | ₹1.83 Cr | ₹68.72 Lakh | ₹15.6 Lakh | ₹23.02 Lakh | ₹26.64 Lakh | ₹27.82 Lakh |
| Depreciation & Amortisation | ₹12.01 Cr | ₹10.24 Cr | ₹7.46 Cr | ₹6.36 Cr | ₹4.5 Cr | ₹3.91 Cr | ₹3.23 Cr |
| Other Expenses | ₹90.37 Cr | ₹88.38 Cr | ₹63.83 Cr | ₹54.79 Cr | ₹30.6 Cr | ₹29.59 Cr | ₹17.75 Cr |
| Total Expenses | ₹157.81 Cr | ₹136.88 Cr | ₹104.15 Cr | ₹91.67 Cr | ₹67.79 Cr | ₹65.75 Cr | ₹73.48 Cr |
| Profit Before Exceptional Items & Tax | ₹146.89 Cr | ₹151.99 Cr | ₹102.72 Cr | ₹95.6 Cr | ₹97.28 Cr | ₹16.52 Cr | ₹93.68 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹0 | -₹10.61 Cr | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹146.89 Cr | ₹151.99 Cr | ₹102.72 Cr | ₹85 Cr | ₹97.28 Cr | ₹16.52 Cr | ₹93.68 Cr |
| Total Tax Expense | ₹22.35 Cr | ₹10.04 Cr | ₹9.83 Cr | ₹5.73 Cr | ₹11.56 Cr | ₹3.15 Cr | ₹13.09 Lakh |
| Net Profit | ₹124.54 Cr | ₹141.95 Cr | ₹92.89 Cr | ₹79.27 Cr | ₹85.71 Cr | ₹13.36 Cr | ₹93.55 Cr |
| Other Comprehensive Income | -₹94.65 Cr | -₹35.89 Cr | -₹56.62 Cr | -₹217.91 Cr | ₹106.45 Cr | ₹345.76 Cr | -₹16.68 Cr |
| Total Comprehensive Income | ₹29.89 Cr | ₹106.06 Cr | ₹36.27 Cr | -₹138.64 Cr | ₹192.17 Cr | ₹359.13 Cr | ₹76.87 Cr |
| EBITDA (computed) | ₹160.46 Cr | ₹164.06 Cr | ₹110.86 Cr | ₹102.12 Cr | ₹102.01 Cr | ₹20.7 Cr | ₹97.19 Cr |
| Basic EPS | ₹4.85 | ₹5.53 | ₹3.62 | ₹3.09 | ₹3.34 | ₹0.52 | ₹3.64 |
| Diluted EPS | ₹4.85 | ₹5.53 | ₹3.62 | ₹3.09 | ₹3.34 | ₹0.52 | ₹3.64 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Total Assets | ₹957.7 Cr | ₹1,009.83 Cr | ₹945.87 Cr | ₹948.14 Cr |
| Non-current Assets | ₹770.86 Cr | ₹813.52 Cr | ₹812.35 Cr | ₹780.99 Cr |
| Current Assets | ₹186.85 Cr | ₹196.31 Cr | ₹133.52 Cr | ₹167.15 Cr |
| Property, Plant & Equipment | ₹169.95 Cr | ₹135.33 Cr | ₹130.54 Cr | ₹131.83 Cr |
| Inventories | ₹52.24 Cr | ₹99.39 Cr | ₹92.6 Cr | ₹88.61 Cr |
| Trade Receivables | ₹30.21 Cr | ₹27.89 Cr | ₹17.4 Cr | ₹22.68 Cr |
| Cash & Equivalents | ₹1.1 Cr | ₹2.53 Cr | ₹98.6 Lakh | ₹82.69 Lakh |
| Equity (Net Worth) | ₹821.46 Cr | ₹853.19 Cr | ₹808.76 Cr | ₹828.99 Cr |
| Equity Share Capital | ₹51.36 Cr | ₹51.36 Cr | ₹51.36 Cr | ₹51.36 Cr |
| Borrowings (Non-current) | ₹6.61 Cr | ₹10.67 Cr | ₹7.39 Cr | ₹0 |
| Borrowings (Current) | ₹4.03 Cr | ₹3.78 Cr | ₹1.76 Cr | ₹0 |
| Total Debt (computed) | ₹10.64 Cr | ₹14.45 Cr | ₹9.15 Cr | ₹0 |
| Current Liabilities | ₹96.31 Cr | ₹108.28 Cr | ₹89.18 Cr | ₹81.04 Cr |
| Total Liabilities | ₹136.25 Cr | ₹156.64 Cr | ₹137.11 Cr | ₹119.16 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | ₹117.4 Cr | ₹81.03 Cr | ₹25.33 Cr | ₹34.7 Cr | -₹21.87 Cr |
| Investing Cash Flow | -₹52.04 Cr | -₹21.79 Cr | ₹22.6 Cr | ₹11.29 Cr | ₹22.66 Cr |
| Financing Cash Flow | -₹66.79 Cr | -₹57.7 Cr | -₹47.77 Cr | -₹46.08 Cr | -₹5.66 Cr |
| Capital Expenditure | ₹38.25 Cr | ₹6.58 Cr | ₹1.39 Cr | ₹4.68 Lakh | ₹1.02 Cr |
| Free Cash Flow (computed) | ₹79.15 Cr | ₹74.45 Cr | ₹23.94 Cr | ₹34.65 Cr | -₹22.88 Cr |
| Dividends Paid | ₹61.41 Cr | ₹61.17 Cr | ₹56.23 Cr | ₹45.92 Cr | ₹5.15 Cr |
| Net Change in Cash | -₹1.43 Cr | ₹1.54 Cr | ₹15.91 Lakh | -₹9.12 Lakh | -₹4.86 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹57.73 Cr | ₹72.28 Cr | ₹54.04 Cr | ₹47.89 Cr | ₹58.22 Cr | ₹55.97 Cr | ₹51.1 Cr | ₹49.08 Cr | ₹47.51 Cr | ₹37.94 Cr | ₹31.15 Cr | ₹35.65 Cr |
| Other Income | ₹2.41 Cr | ₹2.1 Cr | ₹64.8 Cr | ₹3.46 Cr | ₹2.78 Cr | ₹4.25 Cr | ₹65.59 Cr | ₹1.89 Cr | ₹1.95 Cr | ₹2.21 Cr | ₹47.86 Cr | ₹2.59 Cr |
| Total Income | ₹60.14 Cr | ₹74.38 Cr | ₹118.84 Cr | ₹51.34 Cr | ₹61 Cr | ₹60.21 Cr | ₹116.69 Cr | ₹50.97 Cr | ₹49.46 Cr | ₹40.15 Cr | ₹79.01 Cr | ₹38.24 Cr |
| Cost of Materials Consumed | ₹4.04 Cr | ₹3.85 Cr | ₹2.53 Cr | ₹3.45 Cr | ₹1.92 Cr | ₹1.81 Cr | ₹1.41 Cr | ₹2.86 Cr | ₹3.23 Cr | ₹1.58 Cr | ₹2.46 Cr | ₹1.34 Cr |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | -₹64.56 Lakh | ₹1.05 Cr | ₹40.34 Lakh | ₹1.74 Cr | -₹2.62 Lakh | -₹88.26 Lakh | ₹70.81 Lakh | ₹1.31 Cr | -₹1.02 Cr | -₹34.46 Lakh | -₹58.05 Lakh | ₹2.47 Cr |
| Employee Benefit Expense | ₹11.74 Cr | ₹10.32 Cr | ₹7.55 Cr | ₹7.83 Cr | ₹6.5 Cr | ₹6.56 Cr | ₹6.52 Cr | ₹7.73 Cr | ₹5.55 Cr | ₹5.58 Cr | ₹5.63 Cr | ₹6.27 Cr |
| Finance Costs | ₹36.82 Lakh | ₹37.36 Lakh | ₹40.32 Lakh | ₹42.24 Lakh | ₹45.46 Lakh | ₹52.23 Lakh | ₹51.41 Lakh | ₹33.88 Lakh | ₹32.8 Lakh | ₹26.29 Lakh | ₹4.94 Lakh | ₹4.7 Lakh |
| Depreciation & Amortisation | ₹3.25 Cr | ₹3.34 Cr | ₹2.72 Cr | ₹2.7 Cr | ₹2.66 Cr | ₹2.59 Cr | ₹2.59 Cr | ₹2.41 Cr | ₹1.38 Cr | ₹2.57 Cr | ₹1.77 Cr | ₹1.74 Cr |
| Other Expenses | ₹23.05 Cr | ₹30 Cr | ₹21.04 Cr | ₹16.28 Cr | ₹23.81 Cr | ₹22.76 Cr | ₹24.07 Cr | ₹17.73 Cr | ₹16.37 Cr | ₹17.99 Cr | ₹14.01 Cr | ₹15.46 Cr |
| Total Expenses | ₹41.8 Cr | ₹48.94 Cr | ₹34.64 Cr | ₹32.43 Cr | ₹35.32 Cr | ₹33.36 Cr | ₹35.82 Cr | ₹32.38 Cr | ₹25.85 Cr | ₹27.63 Cr | ₹23.34 Cr | ₹27.33 Cr |
| Profit Before Exceptional Items & Tax | ₹18.34 Cr | ₹25.44 Cr | ₹84.19 Cr | ₹18.92 Cr | ₹25.68 Cr | ₹26.85 Cr | ₹80.87 Cr | ₹18.59 Cr | ₹23.61 Cr | ₹12.53 Cr | ₹55.66 Cr | ₹10.91 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹18.34 Cr | ₹25.44 Cr | ₹84.19 Cr | ₹18.92 Cr | ₹25.68 Cr | ₹26.85 Cr | ₹80.87 Cr | ₹18.59 Cr | ₹23.61 Cr | ₹12.53 Cr | ₹55.66 Cr | ₹10.91 Cr |
| Total Tax Expense | ₹8.81 Cr | ₹3.19 Cr | ₹8.56 Cr | ₹1.8 Cr | ₹2.85 Cr | ₹1.16 Cr | ₹4.27 Cr | ₹1.76 Cr | ₹2.93 Cr | ₹1.24 Cr | ₹4.23 Cr | ₹1.43 Cr |
| Net Profit | ₹9.53 Cr | ₹22.26 Cr | ₹75.63 Cr | ₹17.12 Cr | ₹22.83 Cr | ₹25.69 Cr | ₹76.6 Cr | ₹16.84 Cr | ₹20.68 Cr | ₹11.29 Cr | ₹51.43 Cr | ₹9.48 Cr |
| Other Comprehensive Income | -₹104.29 Cr | -₹119.24 Cr | ₹124.64 Cr | ₹4.24 Cr | -₹22.9 Cr | -₹20.93 Cr | -₹31.55 Cr | ₹39.49 Cr | -₹50.37 Cr | -₹14.29 Cr | -₹27.5 Cr | ₹35.54 Cr |
| Total Comprehensive Income | -₹94.76 Cr | -₹96.98 Cr | ₹200.27 Cr | ₹21.36 Cr | -₹7.38 Lakh | ₹4.76 Cr | ₹45.05 Cr | ₹56.33 Cr | -₹29.69 Cr | -₹3 Cr | ₹23.94 Cr | ₹45.02 Cr |
| EBITDA (computed) | ₹21.96 Cr | ₹29.16 Cr | ₹87.32 Cr | ₹22.04 Cr | ₹28.79 Cr | ₹29.97 Cr | ₹83.97 Cr | ₹21.34 Cr | ₹25.33 Cr | ₹15.35 Cr | ₹57.48 Cr | ₹12.7 Cr |
| Basic EPS | ₹0.37 | ₹0.87 | ₹2.95 | ₹0.67 | ₹0.89 | ₹1.00 | ₹2.98 | ₹0.66 | ₹0.81 | ₹0.44 | ₹2.00 | ₹0.37 |
| Diluted EPS | ₹0.37 | ₹0.87 | ₹2.95 | ₹0.67 | ₹0.89 | ₹1.00 | ₹2.98 | ₹0.66 | ₹0.81 | ₹0.44 | ₹2.00 | ₹0.37 |
| Segment · Q4 FY26 (latest quarter) | Revenue | Result (PBIT) | Assets | Liabilities |
|---|---|---|---|---|
| Active Pharmaceutical Ingredients Business | ₹9.83 Cr | -₹1.17 Cr | ₹180.81 Cr | ₹34.8 Cr |
| Real Estate Business | ₹47.9 Cr | ₹20.67 Cr | ₹501.65 Cr | ₹71.9 Cr |
| Segment · FY 2026 (annual) | Revenue | Result (PBIT) | Assets | Liabilities |
|---|---|---|---|---|
| Active Pharmaceutical Ingredients Business | ₹46.59 Cr | ₹5.65 Cr | - | - |
| Real Estate Business | ₹185.35 Cr | ₹78.59 Cr | - | - |
Shareholding Pattern of Alembic Limited
As per the shareholding pattern filed with NSE for the quarter ended Mar 2026, promoters hold 70.88%, foreign institutional investors hold 1.25%, domestic institutional investors hold 0.05%, retail and other public shareholders hold 27.82% of Alembic Limited. The company had 102,008 shareholders on record.
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Promoters | 70.88% | 70.88% | 70.88% | 70.88% | 70.88% | 70.88% |
| Public | 29.12% | 29.12% | 29.12% | 29.12% | 29.12% | 29.12% |
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 70.88% | 70.88% | 70.88% | 70.88% | 70.88% | 70.88% | 67.62% | 64.57% | 63.71% | 65.77% | 64.46% |
| Public | 29.12% | 29.12% | 29.12% | 29.12% | 29.12% | 29.12% | 32.38% | 35.43% | 36.29% | 34.23% | 35.54% |
| Promoter change (YoY, %pts) | +0.00 | +0.00 | +0.00 | +0.00 | +0.00 | +3.26 | +3.05 | +0.86 | -2.06 | +1.31 | - |
Board & Governance of Alembic Limited
As per the corporate governance filing with NSE for the quarter ended 31-MAR-2026, the board of Alembic Limited has 8 directors - 4 independent and 1 executive. The board is chaired by Chirayu Ramanbhai Amin.
| Director | Position | On board since | Listed boards |
|---|---|---|---|
| Chirayu Ramanbhai Amin | Non-Executive - Non Independent Director · Chairperson | 1967-08-20 | 3 |
| Malika Chirayu Amin | Non-Executive - Non Independent Director | 1988-07-02 | 1 |
| Udit Chirayu Amin | Executive Director · MD | 2013-04-24 | 2 |
| Rati Ajay Desai | Non-Executive - Independent Director | 2019-08-13 | 1 |
| Girish Srinivasiah Hirode | Non-Executive - Independent Director | 2023-08-10 | 1 |
| Mayurdhvaj Dilipsinh Jadeja | Non-Executive - Independent Director | 2025-02-07 | 1 |
| Sanjeev Virendra Shah | Non-Executive - Independent Director | 2025-02-07 | 1 |
| Jain Parkash | Non-Executive - Non Independent Director | 2025-02-08 | 1 |
| Committee | Members |
|---|---|
| Audit Committee | Rati Ajay Desai (Chairperson), Mayurdhvaj Dilipsinh Jadeja, Sanjeev Virendra Shah |
| Nomination and remuneration committee | Rati Ajay Desai (Chairperson), Girish Srinivasiah Hirode, Mayurdhvaj Dilipsinh Jadeja, Sanjeev Virendra Shah |
| Stakeholders Relationship Committee | Mayurdhvaj Dilipsinh Jadeja (Chairperson), Udit Chirayu Amin, Sanjeev Virendra Shah |
| Risk Management Committee | Rati Ajay Desai (Chairperson), Jain Parkash, Avaneeshnath Sharma |
| Corporate Social Responsibility Committee | Malika Chirayu Amin (Chairperson), Mayurdhvaj Dilipsinh Jadeja, Rati Ajay Desai |
Group Structure of Alembic Limited
Alembic Limited has 1 subsidiary company and 1 associated company. This group structure data is as of FY 2023. The corporate group structure reflects Alembic Limited's business expansion strategy and organizational complexity.
| Company Name | CIN | Shares Held |
|---|---|---|
| Alembic City Limited | U70100GJ1994PLC021552 | - |
Showing major subsidiaries. Total: 1.
Charges & Borrowings of Alembic Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Sep 2023 | Others | ₹31 Cr | Open |
| 08 May 2006 | Others | ₹36 Cr | Open |
| 25 Sep 2009 | Idbi Trusteeship Services Limited | ₹25 Cr | Satisfied |
| 11 Aug 2009 | Idbi Trusteeship Services Limited | ₹25 Cr | Satisfied |
| 13 Sep 2007 | Idbi Trusteeship Services Ltd | ₹75 Cr | Satisfied |
Total charge records: 21 View all charges
Employees and EPFO Compliance at Alembic Limited
Alembic Limited has a workforce of 287 employees as of Apr 07, 2024.
Employee Count & EPFO Data of Alembic Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Alembic Limited
GSTIN & GST Filing Data of Alembic Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Alembic Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Alembic Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Alembic Limited
MSME Payment Delays by Alembic Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Alembic Limited
Subsidiaries & Group Companies of Alembic Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Alembic Limited with ownership details.
MCA Filings & Documents of Alembic Limited
MCA Filings & Documents of Alembic Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Alembic Limited
Recent News on Alembic Limited
Frequently Asked Questions about Alembic Limited
Alembic Limited is an active public limited company in the pharma sector based in Baroda, Gujarat, India. It was incorporated on 30 July 1907 (119+ years old) and is registered under CIN L26100GJ1907PLC000033. Listed on BSE: 506235 and NSE: ALEMBICLTD. The company has 287 employees.
Alembic Limited reported revenue of ₹296.78 Cr for FY 2025 (up 40.00% YoY).
The current directors of Alembic Limited are:
The primary industry of Alembic Limited is pharma. The company specifically operates in api manufacturers. The company is currently active in this sector.
Yes. Alembic Limited is listed on both BSE (code: 506235) and NSE (symbol: ALEMBICLTD).
Alembic Limited can be reached at the registered office: Alembic Road, Baroda, Gujarat, India – 390003, or through the website alembiclimited.com.